Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001973141-25-000045
Filing Date
2025-01-27
Accepted
2025-01-27 16:01:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 5205
  Complete submission text file 0001973141-25-000045.txt   6804
Mailing Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142
Business Address 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 (617) 551-8200
ALNYLAM PHARMACEUTICALS, INC. (Subject) CIK: 0001178670 (see all company filings)

EIN.: 770602661 | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36407 | Film No.: 25558813
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O SQZ BIOTECHNOLOGIES COMPANY 200 ARSENAL YARDS BOULEVARD, SUITE 210 WATERTOWN MA 02472
Business Address
Garg Pushkal (Reporting) CIK: 0001829252 (see all company filings)

Type: 144